These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31235175)

  • 1. Ambivalence about the selection of cardiovascular risk stratification tools: Evidence in a type 1 diabetes population.
    Bovi TG; Zantut-Wittmann DE; Parisi MCR
    Diabetes Metab Syndr; 2019; 13(3):2322-2327. PubMed ID: 31235175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of coronary artery calcium score and cardiovascular risk-stratification by European Society of Cardiology Guidelines and Steno Type 1 Risk Engine in statin-naïve adults with type 1 diabetes.
    Goh YA; Lan NSR; Linn K; Wood C; Gupta A; Yeap BB; Fegan PG
    J Diabetes Complications; 2023 Aug; 37(8):108557. PubMed ID: 37473636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to improve statin prescription guidelines in low-risk patients?
    Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
    Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cardiovascular risk in adults with type 1 diabetes: poor concordance between the 2019 ESC risk classification and 10-year cardiovascular risk prediction according to the Steno Type 1 Risk Engine.
    Tecce N; Masulli M; Lupoli R; Della Pepa G; Bozzetto L; Palmisano L; Rivellese AA; Riccardi G; Capaldo B
    Cardiovasc Diabetol; 2020 Oct; 19(1):166. PubMed ID: 33010807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses.
    Garg N; Muduli SK; Kapoor A; Tewari S; Kumar S; Khanna R; Goel PK
    Indian Heart J; 2017; 69(4):458-463. PubMed ID: 28822511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk.
    Serés-Noriega T; Giménez M; Perea V; Boswell L; Viñals C; Blanco J; Vinagre I; Pané A; Esmatjes E; Conget I; Amor AJ
    Diabetes Care; 2022 Oct; 45(10):2412-2421. PubMed ID: 35944257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the Steno type 1 risk engine for cardiovascular disease prediction in Italian patients with type 1 diabetes.
    Boscari F; Morieri ML; Amato AML; Vallone V; Uliana A; Baritussio A; Vitturi N; Cipponeri E; Cavallin F; Avogaro A; Fadini GP; Bruttomesso D
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1813-1819. PubMed ID: 32807633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin prescription among patients with type 2 diabetes in Botswana: findings and implications.
    Mwita JC; Godman B; Esterhuizen TM
    BMC Endocr Disord; 2020 Mar; 20(1):36. PubMed ID: 32151249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
    Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
    BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular or chronological age: which is the better marker to estimate the cardiovascular risk in patients with type 1 diabetes?
    de Andrade CRM; Silva ELC; da Matta MFB; Castier MB; Rosa MLG; Gomes MB
    Acta Diabetol; 2016 Dec; 53(6):925-933. PubMed ID: 27528365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA).
    Pease A; Earnest A; Ranasinha S; Nanayakkara N; Liew D; Wischer N; Andrikopoulos S; Zoungas S
    Cardiovasc Diabetol; 2018 Jun; 17(1):77. PubMed ID: 29859534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of cardiovascular medicines in newly treated type 2 diabetes patients: A retrospective cohort study in general practice.
    Grimes RT; Ensor J; Bennett K; Henman MC
    Prim Care Diabetes; 2016 Aug; 10(4):237-43. PubMed ID: 26654852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cardiovascular risk calculators in patients with diabetes.
    Ribeiro LK; Amorim WW; Cardoso ITA; Vieira WS; Kochergin CN; Medeiros DS; Soares DA; Louzado JA; Silva KO; Cortes ML; Mistro S; Bezerra VM; Oliveira MG
    Rev Assoc Med Bras (1992); 2021 Feb; 67(2):200-206. PubMed ID: 34406242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin Therapy: Diabetes Mellitus Risk and Cardiovascular Benefit in Primary Prevention.
    Porath A; Arbelle JE; Fund N; Cohen A; Mosseri M
    Isr Med Assoc J; 2018 Aug; 20(8):480-485. PubMed ID: 30084572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use in adults at high risk of cardiovascular disease mortality: cross-sectional analysis of baseline data from The Irish Longitudinal Study on Ageing (TILDA).
    Murphy C; Bennett K; Fahey T; Shelley E; Graham I; Kenny RA
    BMJ Open; 2015 Jul; 5(7):e008017. PubMed ID: 26169806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study.
    Pavlović J; Greenland P; Deckers JW; Kavousi M; Hofman A; Ikram MA; Franco OH; Leening MJ
    Eur J Prev Cardiol; 2018 Mar; 25(4):420-431. PubMed ID: 29171772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CV risk prediction tools: Imperfect, Yes, but are they serviceable?
    Firnhaber JM
    J Fam Pract; 2018 Sep; 67(9):E3-E8. PubMed ID: 30216402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.